Medscape Medical NewsAll articles

CardioLogs ECG Analysis Platform

Cardiologs Technologies • Cardiovascular • 06/26/2017

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

The CardioLogs ECG Analysis Platform aims to assist healthcare professionals in arrhythmia assessment by using a proprietary, cloud-based algorithm for comprehensive ECG analysis, including delineation, feature extraction, interval and heart rate measurement, and rhythm analysis from various digital ECG sources. Its methodology combines secure data upload, automated algorithmic processing providing abnormality scores, and an interface for physician review and confirmation, representing a modern software solution for clinical ECG interpretation support.

Summary

The CardioLogs ECG Analysis Platform is a software tool designed for qualified healthcare professionals to assess arrhythmias in adult patients (over 18 years old) using electrocardiogram (ECG) data. The platform supports the download and analysis of ECG data from various compatible diagnostic devices such as Holter monitors, event recorders, and 12-lead ambulatory ECGs, and can also interface with other computer-based ECG systems. Its functionalities include ECG signal processing, QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis, facilitated by uploading digital ECG files to secure, HIPAA-compliant databases either manually via a web interface or automatically through an API. At its core, the system employs a proprietary ECG interpretation support algorithm to process these uploaded ECGs, performing delineation (detecting P waves, QRS complexes, T waves) and providing probability scores for a predefined set of abnormality labels. This cloud-based Platform as a Service (PaaS), accessed via a client-side application website built with modern web technologies, displays the analysis alongside the original ECG signal and offers tools for physician review, editing, and confirmation. The platform underwent comprehensive verification and validation testing against recognized industry standards, including usability and software lifecycle processes, meeting all requirements; its interpretation results serve as an advisory aid to clinicians, complementing their overall diagnostic evaluation, and it is not intended for life-supporting systems or as an ECG monitor/alarm device.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

ECG Analysis PlatformArrhythmia AssessmentProprietary AlgorithmCloud-based SystemQRS DetectionVentricular Ectopic Beat DetectionECG Interpretation SupportDigital ECG DataHeart Rate MeasurementRhythm Analysis

Device Metadata

Submission Number
K170568
Company
Cardiologs Technologies
Panel
Cardiovascular
Product Code
N/A
Data Type
Signals
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
detection/diagnosis

Relevant Clinical Questions

  • Q1. What specific arrhythmia classifications does the proprietary algorithm support, and what are its performance metrics (sensitivity, specificity, accuracy) for each, particularly in comparison to established databases or expert cardiologist consensus?; Considering the cloud-based architecture, what are the detailed data security measures, encryption protocols, and compliance certifications (beyond HIPAA) ensuring patient data integrity and confidentiality during upload, storage, processing, and physician access?; How does the platform handle ECGs with significant noise or artifacts, and are there pre-processing steps or algorithm robustness features to mitigate their impact on analysis accuracy?; What is the average turnaround time for ECG analysis, from upload to display of results for physician review, especially for large datasets like 24/48-hour Holter recordings?; Can the physician's edits and confirmations of the algorithm's findings be systematically collected and used as feedback to potentially retrain or refine the proprietary algorithm over time, and if so, what is that process?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score35/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, dataset, feature extraction)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(cloud, platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials(encryption)
✓ Detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, CBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
CardioLogs ECG Analysis Platform - Cardiologs Technologies | ESL FDA AI Device Intelligence